Optical coherence tomography of the retina: Applications in neurology

Current Opinion in Neurology

Volumn 23, Issue 1, 2010, Pages 16-23

  Jindahra, Panitha ^a   Hedges, Thomas R ^b   Mendoza Santiesteban, Carlos E ^c   Plant, Gordon T ^a,d,e  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b TUFTS UNIVERSITY   (United States)

^c Cuban Institute of Ophthalmology 'Ramón Pando Ferrer'   (Cuba)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Alzheimer disease; Multiple sclerosis; Neuromyelitis optica; Optic neuritis; Optical coherence tomography; Parkinson disease; Retinal nerve fibre layer thickness

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; EVOKED VISUAL RESPONSE; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGY; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; RETINA; RETINA GANGLION CELL; REVIEW;

ALZHEIMER DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; OPTIC NERVE; OPTIC NEURITIS; PARKINSON DISEASE; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 74049122814     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328334e99b     Document Type: Review

References (53)

1. Huang D,Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991; 254:1178-1181.
2. Fujimoto JG, Brezinski ME, Tearney GJ, et al. Optical biopsy and imaging using optical coherence tomography. Nat Med 1995; 1:970-972.
3. Costa RA, Mirian S, Luiz RAS, et al. Retinal assessment using optical coherence tomography. Prog Retin Eye Res 2006; 25:325-353.
4. van Velthoven ME, Faber DJ, Verbraak FD, et al. Recent developments in optical coherence tomography for imaging the retina. Prog Retin Eye Res 2007; 26:57-77.
5. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372:1502-1517.
6. McDonald WI. Multiple sclerosis: epidemiology and HLA associations. Ann N Y Acad Sci 1984; 436:109-117.
7. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338:278-285.
8. Zaveri MS, Conger A, Salter A, et al. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol 2008; 65:924-928.
9. Pueyo V, Ara JR, Almarcegui C, et al. Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis. Acta Ophthalmol 2009; 87:1-5.
10. Frohman EM, Dwyer MG, Frohman T, et al. Relationship of optic nerve and brain conventional and nonconventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci 2009; 282 (1-2):96-105.
11. Kolappan M, Henderson AP, Jenkins TM, et al. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol 2009; 256:305-319.
12. Iester M, Cioli F, Uccelli A, et al. Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. Eye 2009; 23:407-412.
13. Siger M, Dziegielewski K, Jasek L, et al. Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol 2008; 255:1555-1560.
14. Costello F, Hodge W, Pan YI, et al. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler 2008; 14:893-905.
15. Plant GT. Optic neuritis and multiple sclerosis. Curr Opin Neurol 2008; 21:16-21.
16. Henderson AP, Trip SA, Schlottmann PG, et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008; 131 (Pt 1):277-287.
17. Pulicken M, Gordon-Lipkin E, Balcer LJ, et al. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007; 69:2085-2092.
18. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69:1603-1609.
19. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, et al. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68:1488-1494.
20. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113:324-332.
21. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58:383-391.
22. Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999; 40:2520-2527.
23. Pueyo V, Martin J, Fernandez J, et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 2008; 14:609-614.
24. Knighton RW, Huang XR, Greenfield DS. Analytical model of scanning laser polarimetry for retinal nerve fiber layer assessment. Invest Ophthalmol Vis Sci 2002; 43:383-392.
25. Yeh E, Weinstock-Guttman B, Lincoff N, et al. Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset. Mult Scler 2009; 15:802-810.
26. Toledo J, Sepulcre J, Salinas-Alaman A, et al. Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Mult Scler 2008; 14:906-912.
27. Costello F, Hodge W, Pan YI, et al. Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes. J Neurol Sci 2009; 281 (1-2):74-79.
28. Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci 2008; 268 (1-2):12-17.
29. Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology 2009; 73:46-52.
30. Klistorner A, Arvind H, Nguyen T, et al. Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann Neurol 2008; 64:325-331.
31. Merle H, Olindo S, Donnio A, et al. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci 2008; 49:4412-4417.
32. de Seze J, Blanc F, Jeanjean L, et al. Optical coherence tomography in neuromyelitis optica. Arch Neurol 2008; 65:920-923.
33. Ratchford JN, Quigg ME, Conger A, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009; 73:302-308.
34. Green AJ, Cree BA. Distinctive retinal nerve fiber layer and vascular changes in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2009; 80:1002-1005.
35. Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009; 72:1077-1082.
36. Terris J, Ecelbarger CA, Marples D, et al. Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol 1995; 269 (6 Pt 2):F775-F785.
37. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 1986; 315:485-487.
38. Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 1989; 501:364-372.
39. Blanks JC, Schmidt SY, Torigoe Y, et al. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL Neurobiol Aging 1996; 17:385-395.
40. Tsai CS, Ritch R, Schwartz B, et al. Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch Ophthalmol 1991; 109:199-204.
41. Curcio CA, Drucker DN. Retinal ganglion cells in Alzheimer's disease and aging. Ann Neurol 1993; 33:248-257.
42. Danesh-Meyer HV, Birch H, Ku JY, et al. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 2006; 67:1852-1854.
43. Valenti DA. Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography. Neurology 2007; 69:1060.
44. Paquet C, Boissonnot M, Roger F, et al. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2007; 420:97-99.
45. Iseri PK, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006; 26:18-24.
46. Parisi V. Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease. Semin Ophthalmol 2003; 18:50-57.
47. Parisi V, Restuccia R, Fattapposta F, et al. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 2001; 112: 1860-1867.
48. Berisha F, Feke GT, Trempe CL, et al. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007; 48:2285-2289.
49. Djamgoz MB, Hankins MW, Hirano J, Archer SN. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 1997; 37:3509-3529.
50. Harnois C, Di PT. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990; 31:2473-2475.
51. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004; 44:2793-2797.
52. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 2008; 116:137-146.
53. Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009; 127:737-741.